AU2002211612A1 - Methods for the treatment of a traumatic central nervous system injury - Google Patents
Methods for the treatment of a traumatic central nervous system injuryInfo
- Publication number
- AU2002211612A1 AU2002211612A1 AU2002211612A AU1161202A AU2002211612A1 AU 2002211612 A1 AU2002211612 A1 AU 2002211612A1 AU 2002211612 A AU2002211612 A AU 2002211612A AU 1161202 A AU1161202 A AU 1161202A AU 2002211612 A1 AU2002211612 A1 AU 2002211612A1
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- methods
- nervous system
- central nervous
- system injury
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23950500P | 2000-10-11 | 2000-10-11 | |
US60/239,505 | 2000-10-11 | ||
US24579800P | 2000-11-03 | 2000-11-03 | |
US60/245,798 | 2000-11-03 | ||
US09/973,375 US20020072509A1 (en) | 2000-10-11 | 2001-10-09 | Methods for the treatment of a traumatic central nervous system injury |
US09/973,375 | 2001-10-09 | ||
PCT/US2001/031705 WO2002030409A2 (en) | 2000-10-11 | 2001-10-10 | Methods for the treatment of a traumatic central nervous system injury |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002211612A1 true AU2002211612A1 (en) | 2002-04-22 |
Family
ID=27399245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002211612A Abandoned AU2002211612A1 (en) | 2000-10-11 | 2001-10-10 | Methods for the treatment of a traumatic central nervous system injury |
Country Status (6)
Country | Link |
---|---|
US (2) | US20020072509A1 (en) |
EP (1) | EP1365752A2 (en) |
JP (1) | JP2004532796A (en) |
AU (1) | AU2002211612A1 (en) |
CA (1) | CA2425650A1 (en) |
WO (1) | WO2002030409A2 (en) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0104423D0 (en) * | 2001-12-27 | 2001-12-27 | Umecrine Ab | Pregnane steroids and their use in the treatment of CNS disorders |
US6967194B1 (en) * | 2002-09-18 | 2005-11-22 | Susan Matsuo | Bio-identical hormones and method of use |
US9339508B2 (en) * | 2003-01-17 | 2016-05-17 | Mapreg | Use of 3-methoxy-pregnenolone for the preparation of a drug for treating a traumatic brain injury |
FR2850023B1 (en) * | 2003-01-17 | 2007-04-06 | Mapreg | DRUGS FOR THE NERVOUS SYSTEM |
KR101288265B1 (en) * | 2003-09-03 | 2013-07-26 | 미스콘 트레이딩 에스.에이. | Methods for the treatment of endometriosis |
PT1530965E (en) | 2003-11-11 | 2006-05-31 | Udo Mattern | ADMINISTRATION SYSTEM FOR CONTROLLED LIBERATION OF SEXUAL HORMONES FOR NASAL APPLICATION |
US8784869B2 (en) | 2003-11-11 | 2014-07-22 | Mattern Pharma Ag | Controlled release delivery system for nasal applications and methods of treatment |
WO2005061088A1 (en) * | 2003-12-22 | 2005-07-07 | Finlay Warren H | Powder formation by atmospheric spray-freeze drying |
US8604011B2 (en) * | 2004-09-27 | 2013-12-10 | The Regents Of The University Of California | Therapy for treatment of chronic degenerative brain diseases and nervous system injury |
ES2428313T3 (en) * | 2005-03-24 | 2013-11-07 | Emory University | Methods for the treatment of lesions of the central nervous system by means of a decreasing administration protocol |
US7473687B2 (en) | 2005-03-24 | 2009-01-06 | Emory University | Methods for the treatment of a traumatic central nervous system injury |
FR2886549B1 (en) * | 2005-06-06 | 2007-09-07 | Biocodex | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CEREBRAL EDEMA |
PT2068825E (en) | 2006-10-04 | 2011-02-11 | M & P Patent Ag | Controlled release delivery system for nasal application of neurotransmitters |
US20090203658A1 (en) * | 2007-01-08 | 2009-08-13 | Duke University | Neuroactive steroid compositions and methods of use therefor |
EP2167098B1 (en) * | 2007-06-11 | 2018-09-05 | University Of Southern California | Allopregnanolone in a method for enhancing neurological function (alzheimer disease) |
US20100204192A1 (en) | 2007-06-11 | 2010-08-12 | University Of Sourthern California | Agents, compositions and methods for enhancing neurological function |
EP2260052A4 (en) * | 2008-02-26 | 2013-01-16 | Univ Emory | Steroid analogues for neuroprotection |
US20110171134A1 (en) * | 2008-06-25 | 2011-07-14 | Iskandar Bermans J | (6s)-5-methyltetrahydrofolic acid for therapy of tissue injury |
WO2010088409A2 (en) * | 2009-01-30 | 2010-08-05 | Emory University | Methods of neuroprotection using neuroprotective steroids and a vitamin d |
US20130040923A1 (en) | 2011-05-13 | 2013-02-14 | Trimel Pharmaceuticals Corporation | Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
US20130045958A1 (en) | 2011-05-13 | 2013-02-21 | Trimel Pharmaceuticals Corporation | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US10328152B2 (en) | 2011-06-16 | 2019-06-25 | Nayan Patel | Method for stabilization and delivery of therapeutic molecules |
WO2013043985A1 (en) | 2011-09-23 | 2013-03-28 | The Regents Of The University Of California | Edible oils to enhance delivery of orally administered steroids |
BR112014008328A2 (en) * | 2011-10-07 | 2017-04-18 | Florida State Univ Res Found | nasal delivery mechanism for prophylactic and post acute use of progesterone and / or its enantiomer for use in the treatment of mild traumatic brain injury |
BR112014018110B1 (en) * | 2012-01-23 | 2022-06-07 | Sage Therapeutics, Inc | Aqueous pharmaceutical compositions formulated for parenteral administration and use of allopregnanolone and sulfbutylether-b-cyclodextrin |
CA2892811A1 (en) | 2012-11-30 | 2014-06-05 | The Regents Of The University Of California | Allopregnanolone and a sulfobutylether-b-cyclodextrin salt for the treatment of post-partum depression |
US8992951B2 (en) * | 2013-01-09 | 2015-03-31 | Sapna Life Sciences Corporation | Formulations, procedures, methods and combinations thereof for reducing or preventing the development, or the risk of development, of neuropathology as a result of trauma |
US11744838B2 (en) | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
US9321803B2 (en) * | 2013-07-12 | 2016-04-26 | Children's Hospital Medical Center | Compositions and methods for inhibiting norovirus infection |
DK3033350T3 (en) | 2013-08-12 | 2021-08-30 | Univ Emory | PROGESTERONE PHOSPHATE ANALOGS AND USES RELATED THEREOF |
EP3426257A4 (en) | 2016-03-08 | 2019-11-13 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
CN110381991B (en) | 2017-03-28 | 2024-04-09 | 儿童医院医学中心 | Norovirus S particle vaccines and methods of making and using the same |
WO2019226515A1 (en) * | 2018-05-21 | 2019-11-28 | The University Of North Carolina At Chapel Hill | Methods of inhibiting proinflammatory neuroimmune signaling and treating inflammatory disorders |
WO2024072910A1 (en) * | 2022-09-27 | 2024-04-04 | Marv Enterprises, LLC | Composition for Acutely Decreasing Pathophysiologic Effects from a Concussion and a Method of Administering Thereof |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4404366A (en) * | 1980-05-06 | 1983-09-13 | Miles Laboratories, Inc. | Beta-galactosyl-umbelliferone-labeled hapten conjugates |
US5120723A (en) * | 1987-08-25 | 1992-06-09 | University Of Southern California | Method, compositions, and compounds for modulating brain excitability |
US5232917A (en) * | 1987-08-25 | 1993-08-03 | University Of Southern California | Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
USRE35517E (en) * | 1987-08-25 | 1997-05-20 | University Of Southern California | Method, compositions, and compounds for modulating brain excitability |
US5068226A (en) * | 1987-12-07 | 1991-11-26 | Cyclex, Inc. | Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies |
US5212167A (en) * | 1991-09-12 | 1993-05-18 | Trustees Of Boston University | Modulation of receptor-mediated ion transport |
US5206415A (en) * | 1991-12-20 | 1993-04-27 | Washington University | Tricyclic steroid analogs |
US5776923A (en) * | 1993-01-19 | 1998-07-07 | Endorecherche, Inc. | Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone |
AU5855794A (en) * | 1993-01-19 | 1994-08-15 | Endorecherche Inc. | Therapeutic uses and delivery systems of dehydroepiandrosterone |
US5763431A (en) * | 1993-08-20 | 1998-06-09 | Jackson; Meyer B. | Method for regulating neuropeptide hormone secretion |
WO1995005826A1 (en) * | 1993-08-20 | 1995-03-02 | Jackson Meyer B | Method for regulating neuropeptide hormone secretion |
US5939545A (en) * | 1994-02-14 | 1999-08-17 | Cocensys, Inc. | Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
FR2727117A1 (en) * | 1994-11-18 | 1996-05-24 | Geffard Michel | USE OF POLYLYSIN CONJUGATES FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES AND DEGENERATIVE DISORDERS OF AUTOIMMUN CHARACTER |
US5767117A (en) * | 1994-11-18 | 1998-06-16 | The General Hospital Corporation | Method for treating vascular headaches |
US5741899A (en) * | 1995-02-02 | 1998-04-21 | Cell Genesys, Inc. | Chimeric receptors comprising janus kinase for regulating cellular pro liferation |
DE69634039T2 (en) * | 1995-06-06 | 2005-12-08 | Euro-Celtique S.A. | Steroid derivatives of the androstane and pregnane series |
US5942241A (en) * | 1995-06-09 | 1999-08-24 | Euro-Celtique, S.A. | Formulations and methods for providing prolonged local anesthesia |
US5888996A (en) * | 1995-07-26 | 1999-03-30 | Trustees Of Boston University | Inhibition of NMDA receptor activity and modulation of glutamate-mediated synaptic activity |
US5763492A (en) * | 1996-10-01 | 1998-06-09 | Duguesne University Of The Holy Ghost | Methods for effecting memory enhancement mediated by non-steroidal sulfatase inhibitors |
US6245757B1 (en) * | 1997-10-03 | 2001-06-12 | Research Corporation Technologies, Inc. | Use of progestins to treat ischemic event |
ATE307592T1 (en) * | 1998-03-11 | 2005-11-15 | Torbjoern Backstroem | EPIALLOPREGNANOLONE FOR THE TREATMENT OF CNS DISEASES |
-
2001
- 2001-10-09 US US09/973,375 patent/US20020072509A1/en not_active Abandoned
- 2001-10-10 JP JP2002533852A patent/JP2004532796A/en active Pending
- 2001-10-10 EP EP01979677A patent/EP1365752A2/en not_active Withdrawn
- 2001-10-10 AU AU2002211612A patent/AU2002211612A1/en not_active Abandoned
- 2001-10-10 WO PCT/US2001/031705 patent/WO2002030409A2/en not_active Application Discontinuation
- 2001-10-10 CA CA002425650A patent/CA2425650A1/en not_active Abandoned
-
2005
- 2005-03-22 US US11/085,889 patent/US20050187188A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20050187188A1 (en) | 2005-08-25 |
US20020072509A1 (en) | 2002-06-13 |
WO2002030409A8 (en) | 2002-09-19 |
EP1365752A2 (en) | 2003-12-03 |
JP2004532796A (en) | 2004-10-28 |
CA2425650A1 (en) | 2002-04-18 |
WO2002030409A9 (en) | 2003-05-01 |
WO2002030409A2 (en) | 2002-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002030409A8 (en) | Methods for the treatment of a traumatic central nervous system injury | |
AUPQ514600A0 (en) | Brain injury treatment | |
PL373626A1 (en) | Treatment for central nervous system disorders | |
IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
GB0007193D0 (en) | Treatment of movrmrnt disorders | |
IL155589A0 (en) | Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders | |
AU6910600A (en) | Methods for the treatment of mental disorders | |
AU2002210462A1 (en) | Transdermal therapeutic system for treating restless-legs-syndrome | |
AU2001277112A1 (en) | Device providing regulated growth factor delivery for the regeneration of peripheral nerves | |
AU2002217447A1 (en) | Apparatus for lipolysis for aesthetic treatment | |
AU2001293891A1 (en) | New combination for the treatment of asthma | |
AU2002227895A1 (en) | Sulphonamides for the treatment of central nervous system diseases | |
AU2739497A (en) | Use of vitamin d analogs for the treatment of arthritic disease | |
EP1181308A4 (en) | Methods for the treatment of neuronal atrophy-associated dementia | |
AU2001280133A1 (en) | Preventives and remedies for central nervous system diseases | |
AU2002225327A1 (en) | Apparatus for aesthetic treatment | |
AU2080201A (en) | Treatment of addiction disorders | |
AU8339301A (en) | Compounds for the treatment of addictive disorders | |
AU4687501A (en) | Medicine for treating traumatic brain injury and other neuronal disorders | |
AU2504101A (en) | Device for carrying out the oscillation-induced selective treatment of malignantdiseases | |
AU2001269263A1 (en) | Medicaments containing dextrin for treating respiratory disorders such as cysticfibrosis | |
GB0010496D0 (en) | Treatment of conditions of the central nervous system | |
AU2001274446A1 (en) | Vip-related peptides for the treatment of skin disorders | |
AU3805497A (en) | Calpain inhibitors for the treatment of traumatic brain injury | |
AU2002326943A1 (en) | Neuroprotection after traumatic brain injury |